Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2027 By Application, End User and Geography | The Insight Partners

Autologous Stem Cell and Non-Stem Cell Based Therapies Market to 2027 - Global Analysis and Forecasts By Application (Neurodegenerative, Cardiovascular, Cancer and Autoimmune, Skin and Infectious Diseases); End User (Hospitals, Research Institutes) and Geography

Report Code: TIPRE00006725 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Autologous stem-cell transplantation is the autologous transplantation of stem cells. User preserves his own cells which can be used later. This is considered to be one of the effective and safer way to treat the diseases such as cancer. It is safer technology when compared with allogeneic and xeno transplants. IT reduces the risk of disease transmission, bio-incompatibility, and immunological reactions.


MARKET DYNAMICS

The Autologous Stem Cell and Non-Stem Cell Based Therapies market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of cancer and diabetes, growing geriatric population, favorable reimbursement scenarios across several countries.

MARKET SCOPE

The "Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Autologous Stem Cell and Non-Stem Cell Based Therapies market with detailed market segmentation by application, end user, and geography. The global Autologous Stem Cell and Non-Stem Cell Based Therapies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Autologous Stem Cell and Non-Stem Cell Based Therapies market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Autologous Stem Cell and Non-Stem Cell Based Therapies market is segmented on the basis of application and end user. Based on application the market is segmented into Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases. Based on end user, the market is segmented into hospital and research institute.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Autologous Stem Cell and Non-Stem Cell Based Therapies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Autologous Stem Cell and Non-Stem Cell Based Therapies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Autologous Stem Cell and Non-Stem Cell Based Therapies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Autologous Stem Cell and Non-Stem Cell Based Therapies market in these regions.


MARKET PLAYERS


The reports cover key developments in the Autologous Stem Cell and Non-Stem Cell Based Therapies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Autologous Stem Cell and Non-Stem Cell Based Therapies market are anticipated to lucrative growth opportunities in the future with the rising demand for Autologous Stem Cell and Non-Stem Cell Based Therapies market in the global market. Below mentioned is the list of few companies engaged in the Autologous Stem Cell and Non-Stem Cell Based Therapies market.

The report also includes the profiles of key Autologous Stem Cell and Non-Stem Cell Based Therapies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Fibrocell Science, Inc.
  •  Aastrom Biosciences
  •  Dendreon Corporation
  •  NeoStem, Inc.
  •  BrainStorm Cell Therapeutics
  •  Regeneus Ltd.
  •  Genzyme Corporation
  •  Gegenexx
  •  Antria
  •  Bioheart
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autologous Stem Cell And Non-Stem Cell Based Therapies Market - By Application
1.3.2 Autologous Stem Cell And Non-Stem Cell Based Therapies Market - By End User
1.3.3 Autologous Stem Cell And Non-Stem Cell Based Therapies Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES MARKET - GLOBAL MARKET ANALYSIS

6.1. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES - GLOBAL MARKET OVERVIEW
6.2. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. NEURODEGENERATIVE
7.3.1. Overview
7.3.2. Neurodegenerative Market Forecast and Analysis
7.4. CARDIOVASCULAR
7.4.1. Overview
7.4.2. Cardiovascular Market Forecast and Analysis
7.5. CANCER AND AUTOIMMUNE
7.5.1. Overview
7.5.2. Cancer and Autoimmune Market Forecast and Analysis
7.6. SKIN AND INFECTIOUS DISEASES
7.6.1. Overview
7.6.2. Skin and Infectious Diseases Market Forecast and Analysis

8. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - END USER

8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. RESEARCH INSTITUTES
8.4.1. Overview
8.4.2. Research Institutes Market Forecast and Analysis

9. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
9.1.2 North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis
9.1.3 North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Application
9.1.4 North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By End User
9.1.5 North America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Countries
9.1.5.1 United States Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.1.5.1.1 United States Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.1.5.1.2 United States Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.1.5.2 Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.1.5.2.1 Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.1.5.2.2 Canada Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.1.5.3 Mexico Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.1.5.3.1 Mexico Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.1.5.3.2 Mexico Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.2. EUROPE
9.2.1 Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
9.2.2 Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis
9.2.3 Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Application
9.2.4 Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By End User
9.2.5 Europe Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.2.5.1.1 Germany Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.2.5.1.2 Germany Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.2.5.2 France Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.2.5.2.1 France Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.2.5.2.2 France Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.2.5.3 Italy Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.2.5.3.1 Italy Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.2.5.3.2 Italy Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.2.5.4 Spain Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.2.5.4.1 Spain Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.2.5.4.2 Spain Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.2.5.5 United Kingdom Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.2.5.5.1 United Kingdom Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.2.5.5.2 United Kingdom Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
9.3.2 Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis
9.3.3 Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.3.5.1.1 Australia Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.3.5.1.2 Australia Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.3.5.2 China Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.3.5.2.1 China Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.3.5.2.2 China Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.3.5.3 India Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.3.5.3.1 India Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.3.5.3.2 India Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.3.5.4 Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.3.5.4.1 Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.3.5.4.2 Japan Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.3.5.5 South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.3.5.5.1 South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.3.5.5.2 South Korea Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
9.4.2 Middle East and Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis
9.4.3 Middle East and Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.4.5.1.1 South Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.4.5.1.2 South Africa Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.4.5.2 Saudi Arabia Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.4.5.2.1 Saudi Arabia Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.4.5.2.2 Saudi Arabia Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.4.5.3 U.A.E Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.4.5.3.1 U.A.E Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.4.5.3.2 U.A.E Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Overview
9.5.2 South and Central America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis
9.5.3 South and Central America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Application
9.5.4 South and Central America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By End User
9.5.5 South and Central America Autologous Stem Cell And Non-Stem Cell Based Therapies Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.5.5.1.1 Brazil Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.5.5.1.2 Brazil Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User
9.5.5.2 Argentina Autologous Stem Cell And Non-Stem Cell Based Therapies Market
9.5.5.2.1 Argentina Autologous Stem Cell And Non-Stem Cell Based Therapies Market by Application
9.5.5.2.2 Argentina Autologous Stem Cell And Non-Stem Cell Based Therapies Market by End User

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. AUTOLOGOUS STEM CELL AND NON-STEM CELL BASED THERAPIES MARKET, KEY COMPANY PROFILES

11.1. FIBROCELL SCIENCE, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AASTROM BIOSCIENCES
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DENDREON CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. NEOSTEM, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRAINSTORM CELL THERAPEUTICS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. REGENEUS LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GENZYME CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GEGENEXX
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ANTRIA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BIOHEART
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Fibrocell Science, Inc.
2. Aastrom Biosciences
3. Dendreon Corporation
4. NeoStem, Inc.
5. BrainStorm Cell Therapeutics
6. Regeneus Ltd.
7. Genzyme Corporation
8. Gegenexx
9. Antria
10. Bioheart